Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
113K
-
Shares change
-
+77.9K
-
Total reported value, excl. options
-
$14.3M
-
Value change
-
+$9.81M
-
Number of buys
-
3
-
Price
-
$125.95
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2023
4 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q4 2023.
Ascendis Pharma A/S - ADR (ASND) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 113K shares
of 55.6M outstanding shares and own 0.2% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10.1M shares), Artisan Partners Limited Partnership (5.75M shares), FMR LLC (5.11M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (4.03M shares), JANUS HENDERSON GROUP PLC (3.99M shares), T. Rowe Price Investment Management, Inc. (3.99M shares), Avoro Capital Advisors LLC (3.76M shares), WELLINGTON MANAGEMENT GROUP LLP (3.25M shares), Capital International Investors (2.18M shares), and MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1.52M shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.